40th Annual Meeting of the European Association for the Study of the Liver

Conference Reports for NATAP


40th Annual Meeting of the European Association for the Study of the Liver April 13-17, 2005 Paris, France

	HIV & High HCV Viral load Increased HCV Perinatal Transmission (05/05/05) Lack of Pharmacokinetic Interaction When Entecavir is Co-Administerd with Lamivudine,, Adefovir, or Tenofovir and Entecavir Dosing with Renal Impairment (05/05/05) HBV DNA (viral load) Predicts Liver Cirrhosis (05/02/05) Tenofovir in HIV/HBV Coinfection (05/02/05) HOMOSEXUALLY TRANSMITTED HCV-ACUTE INFECTION RELATED TO A CLUSTERED GENOTYPE 4 HCV IN HIV-1 INFECTED MEN AND INEFFICACY OF EARLY ANTIVIRAL THERAPY (05/02/05) Effect of Previous HBV Therapy on Pegasys+Lamivudine for HBV (05/02/05) HBV Viral Load Risk Factor for Liver Cancer (04/27/05) Diabetes & Lipids Associated with Liver Disease (04/27/05) Adefovir for HBV HBeAg-negative: 4 years- safety, antiviral efficacy, resistance, ALT normalization, creatinine & phosphorous (04/27/05) HBV DNA Decline & ALT Normalization Associated with Histologic Improvement (04/27/05) Pegasys for HBV, 72 Weeks: HBsAg Seroconversion Response (04/26/05) Ribavirin Levels & Viral Response to PegIFN/RBV HCV Therapy (04/25/05) SUSTAINED RESPONSE TO PEGASYS IN HBeAg-NEGATIVE CHRONIC HEPATITIS B. (04/25/05) PegIFN/Ribavirin Therapy for Cirrhotics (04/25/05) PegInterferon Maintenance Therapy: EASL Report (04/25/05) Pegasys/RBV Retreatment for IFN/RBV Failures (04/22/05) Adefovir Resistance report: 4 years update (04/22/05) Adefovir Week 144 Efficacy in HBeAg+ (04/20/05) HBV: Entecavir Compared to Adefovir & Lamivudine (04/20/05) Viramidine- New HCV Drug: new 24/48 week Phase II study results (04/19/05) Valtorcitabine (LdC) New HBV Drug Phase I/II Study Results (04/19/05) PegIFN+Adefovir Combination for HBV: cccDNA, seroconversion (04/19/05) NM-283 New HCV Drug, new 24 week data; New Developments in HCV at EASL (04/18/05) Adefovir HBV Resistance Update (04/15/05) Age & Ribavirin Dose Reductions Reduce SVR to Peginterferon+Ribavirin (04/15/05) Cost Effectiveness of Peginterferon in HCV/HIV Coinfection (04/15/05) Albuferon: new HCV drug (04/14/05) New Hep C Drug NM283: 24 week data at EASL (04/14/05) New Hepatitis C Drugs in Development: EASL Report (04/14/05)